TABLE 1.

Summary of Potential Challenges to Provision of MTM + PGx Testing Service by Community Pharmacists

Timing of and Access to PGx Testing Timing of PGx testing for making optimal drug decisions Access to PGx test results done in various clinical care settings Ability of pharmacists to order PGx testing Extended MTM Sessions Pharmacist time constraints in community practice Uncertain added time needed for initial session, and follow-up session needed to introduce testing/discuss test results Uncertain feasibility of discussing PGx testing by phone versus face to face Information Technology Limited access to patient’s electronic health record Need to integrate PGx test information into health technology tools for MTM Training and Workforce Limited PGx education in pharmacy curriculum Need for continuing education as PGx field grows Setting Standards Development of standards for integrating PGx testing into MTM practice to provide consistent and documentable added value Consideration of pharmacist liability Reimbursement Obtaining adequate reimbursement for MTM plus PGx testing ser vice

MTM = medication management therapy; PGx = pharmacogenetic.